Article

Imatinib with intensive chemotherapy in AML with t(9;22)(q34.1;q11.2)/BCR::ABL1. A DATAML registry study.

2024-04-09

Abstract excerpt

<title>Abstract</title> <p>Acute myeloid leukemia (AML) with t(9;22) (q34.1; q11.2)/<italic>BCR::ABL1</italic>, a distinct entity within the group of AML with defining genetic abnormalities, belong to the adverse-risk group of the 2022 ELN classification. However, there is little data on outcome since the era of tyrosine kinase inhibitors. Among 5819 AML cases included in the DATAML registry, 20 patients with de...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 700d5f33-6626-5e1d-a125-26cd25c98c5e
DOI: 10.21203/rs.3.rs-4205555/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Imatinib with intensive chemotherapy in AML with t(9;22)(q34.1;q11.2)/BCR::ABL1. A DATAML registry study.DOI 10.21203/rs.3.rs-4205555/v1Read

Chronic myeloid leukemia: 2022 update on diagnosis, therapy, and monitoringSemantic proximity Read

Chronic myeloid leukemia: 2020 update on diagnosis, therapy and monitoringSemantic proximity Read

Chronic myeloid leukemia: 2018 update on diagnosis, therapy and monitoringSemantic proximity Read

Clinical and genomic characterization of patients diagnosed with the provisional entity acute myeloid leukemia with BCR-ABL1, a Swedish population-based study.Semantic proximity Read

Real-Life Data of Patients with Chronic Myeloid Leukemia in AmazonasSemantic proximity Read

Chronic myeloid leukemia: 2012 update on diagnosis, monitoring, and managementSemantic proximity Read

Validation of the prognostic significance of the 2022 European LeukemiaNet risk stratification system in intensive chemotherapy treated aged 18 to 65 years patients with de novo acute myeloid leukemia.Semantic proximity Read

Chronic myeloid leukemia: 2016 update on diagnosis, therapy, and monitoringSemantic proximity Read

Comparison and validation of the 2022 European LeukemiaNet guidelines in acute myeloid leukemia.Semantic proximity Read

Etoposide plus cytarabine versus cyclophosphamide or melphalan in busulfan-based preparative regimens for autologous stem cell transplantation in adults with acute myeloid leukemia in first complete remission: A study from the Acute Leukemia Working Party of the EBMTSemantic proximity Read

Treatment and molecular monitoring update in chronic myeloid leukemia management.Semantic proximity Read

Mutations in the BCR-ABL1 Kinase Domain and Elsewhere in Chronic Myeloid Leukemia.Semantic proximity Read